18004-75-6Relevant articles and documents
Nucleoside analogs useful as PRMT5 inhibitors
-
Paragraph 0181; 0183; 0187; 0188; 0189, (2021/08/11)
The invention relates to the technical field of biological medicines, and particularly discloses a nucleoside analogue used as a PRMT5 inhibitor. According to the nucleoside analogue as shown in the formula (I) or the pharmaceutically acceptable salt of the nucleoside analogue, the nucleoside analogue or the pharmaceutically acceptable salt of the nucleoside analogue shows relatively high inhibition on the activity of PRMT5 and can be used for preventing and/or treating PRMT5-mediated diseases, and the PRMT5-mediated diseases comprise cell abnormal proliferative diseases.
NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES
-
Page/Page column 113-114, (2012/02/13)
The present invention provides compounds of formula (I) wherein G1, G2, G3, G4, G5, G6, Y1, Y2, Y3, Y4, Y5 and Y6 and p and
NOVEL MICROBIOCIDAL OXIME ETHERS
-
Page/Page column 114, (2012/09/21)
The present invention provides compounds of formula (I) wherein D1, D2, D3, G1, G2, G3, Y3, Y4, Y6, p and X are as defined in the claims. The invention furt